Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Anjarium Biosciences Raises $61M in Series A Financing

16 Sep, 2021

Anjarium Biosciences Raises $61M in Series A Financing
Photo by David Milmont on Unsplash

– Anjarium Biosciences AG is a Schliren, Zurich-based biotech company focused on creating and delivering a new class of non-viral gene therapies.
– Series A funding closed at $61m.
– The round was co-led by Abingworth and Gimv, with participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company).
– The new investment will be used to advance the company’s pipeline programs towards clinical development.

Biotechnology Pharmaceutical Western Europe

Related Posts

Gamma Launches With $7M in Seed Funding

Gamma Launches With $7M in Seed Funding

02 Nov, 2021
Autobrains Announces $101 Million Series C Funding Led by Temasek

Autobrains Announces $101 Million Series C Funding Led by Temasek

02 Nov, 2021
Kianda Technologies Raises €1.5M in Funding

Kianda Technologies Raises €1.5M in Funding

02 Nov, 2021
Tifin Raises $47M in Series C at $447M Valuation

Tifin Raises $47M in Series C at $447M Valuation

02 Nov, 2021

Crunchbase icon

Content report

The following text will be sent to our editors:

Send